TF
JAZZ icon

Trek Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Trek Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.02M Buy
+21,246
New +$3.71M 0.21% 113

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Trek Financial's JAZZ Position: Q1 2026 in Review

Trek Financial opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 21,246 shares worth $4.02M. The stake represents 0.21% of the portfolio and ranks #113 among its holdings.

570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Trek Financial held 21,246 shares of Jazz Pharmaceuticals worth $4.02M as of Q1 2026.
  • Jazz Pharmaceuticals was a new Trek Financial position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.21% of Trek Financial's portfolio in Q1 2026, its #113 holding.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Trek Financial's 13F filing for Q1 2026, filed 13 May 2026.